Data as of 1:04pm ET
| +0.0798 / +9.50%|
The 1 analysts offering 12-month price forecasts for Cardium Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +443.60% increase from the last price of 0.92.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.